MigraineMind research summary

Pharmacological management of vestibular migraine of childhood in a pediatric vestibular program.

Int J Pediatr Otorhinolaryngol | 2026

Observational study
AuthorsDiBlasi M, Pandiscio K, Yun A, Kim HY, Mysak K
JournalInt J Pediatr Otorhinolaryngol
Publication year2026
PubMed ID42906226

Summary

This study looked at medications for treating vestibular migraine in children. Researchers analyzed data from 160 patients aged 18 and under. The patients had vestibular migraine or recurrent vertigo. Doctors used different medications to prevent and relieve symptoms. Preventative medications included cyproheptadine, propranolol, and topiramate. Rescue medications included triptans and NSAIDs. The study aimed to see how well these medications worked. Researchers classified the patients' symptom changes into four categories. They used statistical methods to compare how many patients showed major improvement with each medication. The findings will help doctors understand which medications work best for children with vestibular migraine. This research is important because it provides insights into effective treatments for a challenging condition. It may help improve the quality of life for young patients suffering from vestibular migraines. Clinical relevance: This research identifies effective medications for treating vestibular migraine in children, guiding clinicians in making better treatment choices.

Related migraine research topics

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.